Over £300m was spent by UK consumers on CBD – Cannabidiol – in 2019. This opportunity, expected to grow to £1bn in 2024, is just one of the many uses for industrial hemp, Cannabis sativa. The potential of this versatile crop is to be discussed at the Agri-TechE ‘Farmer to Pharma’ conference in partnership with Hanway Associates.
Eco insulation is one of the many applications for industrial hemp (Cannabis sativa), a plant that is gaining interest as an alternative to oilseed rape in a rotation…
Reforms would unlock the economic potential of CBD production for UK farmers, says George McBride of Hanway
The EIHA is working to create a more logical and consistent framework for regulating the hemp sector
“I’d like to see this UK restriction on the extraction of CBD from industrial hemp removed” says Robert Jappie a Partner at Ince, specialising in Life Science and Cannabinoid Regulation. “Why must we import CBD from overseas when we are perfectly capable of doing the extraction here?
Although the UK can grow Cannabis sativa very well, UK-based Equinox – a vertically integrated cannabis company – currently grows its medicinal and pharmaceutical cannabis in Austria.
“I see hemp as a crop with a great future – with multiple uses in a market that needs developing,” explains John Barrett, Director of Sentry Limited, and speaker at the Agri-TechE event “From Farmer to Pharma”.
The potential of hemp, a variety of Cannabis sativa L. is to be discussed at the Agri-TechE event ‘Farmer to Pharma’, on 12th May.
NovaExtraction has created low-energy extractor that is gaining interest as a means to gain a high yield of cannabidiol (CBD) from leaves of Cannabis sativa. The company will be opening a showroom shortly.
‘From Farmer to Pharma – a Teaser of Things to Come’ is a webinar presented with Hanway Associates, that aims give a heads-up on the benefits and issues involved with growing Cannabis – hailed as the new Wonder-Crop
The worldwide legal cannabis industry generated revenues in the region of £11.5bn in 2019 and is expected to grow to around £35bn by 2024. The potential margins from growing medical cannabis are more lucrative per gram for a grower than strawberries.
Crop17 is a new initiative to support the develop medical cannabis facilities, launched by Savills in partnership with Hanway Associates, a leading cannabis strategic consultancy and CambridgeHOK, an innovative glass-house builder.